Knight Therapeutics Strategic Investments
Corporate venture profile
Knight Therapeutics Strategic Investments is the corporate venture arm of Knight Therapeutics, a pharmaceutical and biotech company. It is based in Montreal, Canada. It invests at the growth stage. Sectors it names: biotech and life sciences, medical devices.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Growth to Growth |
| Sectors | Biotech and life sciences, Medical devices |
| Geography | North America |
| Offices | Montreal, Canada |
Sources: S1 Knight Therapeutics: Knight secures Canadian products in two separate transactions.
Where it invests
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Knight Therapeutics (TSX: GUD) | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Headquarters | Montreal, Canada | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Stages | Growth (inferred from announced rounds) | Estimate | S1 |
About Knight Therapeutics
Recent rounds
| Date | Company | Round | Amount | Led by the firm | Source |
|---|---|---|---|---|---|
| 2015-06-04 | Profound Medical | Not stated | USD 2M | No | S1 |
Portfolio
Portfolio company named in public sources: Profound Medical.S1
Official pages
Read the firm's own pages for current information.
- Website knighttx.com/
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Knight Therapeutics Strategic Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.